Literature DB >> 34377089

Commonly Prescribed and Over-the-Counter Drugs as Secondary Causes of Osteoporosis-Part One.

Joseph Pizzorno, Lara Pizzorno.   

Abstract

Prescription and over-the-counter drugs have been effectively used to manage many diseases and to provide symptom relief. Unfortunately, their use may also result in adverse drug reactions and unintended consequences. Proper use of these powerful agents requires understanding both their desired effects and their potential downsides. Fully understanding the unintended consequences can be challenging. Virtually all safety studies are carried out for far shorter periods of time than the actual use of these agents in the real world. Some may take years of use before their sequelae are recognized. This is especially a problem where bone health is concerned since the damage caused by years of minor disruption in function does not show up until compounded by other factors, such as andropause and menopause. This 2-part editorial covers the primary classes of drugs that require bone health monitoring and that may require alternative prescriptions or mitigation strategies. Part One covers aromatase inhibitors, gonadotropin-releasing hormone agonists, anticonvulsants, benzodiazepines, antidepressants, insulin sensitizers, and NSAIDs and acetaminophen. Part Two covers opioids, glucocorticoids, calcineurin inhibitors, H2 blockers, diuretics, anticoagulants, thyroid medications, and contraceptives.
Copyright © 2021 InnoVision Professional Media Inc.

Entities:  

Year:  2021        PMID: 34377089      PMCID: PMC8325490     

Source DB:  PubMed          Journal:  Integr Med (Encinitas)        ISSN: 1546-993X


  52 in total

1.  Long-term effect of aromatase inhibitors on bone microarchitecture and macroarchitecture in non-osteoporotic postmenopausal women with breast cancer.

Authors:  A R Hong; J H Kim; K H Lee; T Y Kim; S A Im; T Y Kim; H G Moon; W S Han; D Y Noh; S W Kim; C S Shin
Journal:  Osteoporos Int       Date:  2017-01-12       Impact factor: 4.507

2.  Hip/femur fractures associated with the use of benzodiazepines (anxiolytics, hypnotics and related drugs): a methodological approach to assess consistencies across databases from the PROTECT-EU project.

Authors:  Gema Requena; Consuelo Huerta; Helga Gardarsdottir; John Logie; Rocío González-González; Victoria Abbing-Karahagopian; Montserrat Miret; Cornelia Schneider; Patrick C Souverein; Dave Webb; Ana Afonso; Nada Boudiaf; Elisa Martin; Belén Oliva; Arturo Alvarez; Mark C H De Groot; Andrew Bate; Saga Johansson; Raymond Schlienger; Robert Reynolds; Olaf H Klungel; Francisco J de Abajo
Journal:  Pharmacoepidemiol Drug Saf       Date:  2015-06-23       Impact factor: 2.890

Review 3.  Tamoxifen and CYP2D6: A Controversy in Pharmacogenetics.

Authors:  Deirdre P Cronin-Fenton; Per Damkier
Journal:  Adv Pharmacol       Date:  2018-05-07

4.  Depression and antidepressant medications: both are linked to increased fracture risk.

Authors:  Q Wu
Journal:  Osteoporos Int       Date:  2018-11-28       Impact factor: 4.507

5.  Complex metabolic and skeletal changes in men taking long-term androgen deprivation therapy.

Authors:  Stanislav Ziaran; Frederico M Goncalves; Jan Breza Sn
Journal:  Clin Genitourin Cancer       Date:  2012-09-19       Impact factor: 2.872

Review 6.  Osteoporosis in chronic liver disease.

Authors:  Núria Guañabens; Albert Parés
Journal:  Liver Int       Date:  2018-03-25       Impact factor: 5.828

7.  Association between use of antidepressants or benzodiazepines and the risk of subsequent fracture among those aged 65+ in the Netherlands.

Authors:  L I van de Ven; C Klop; J A Overbeek; F de Vries; A M Burden; P K Janssen
Journal:  Osteoporos Int       Date:  2018-08-15       Impact factor: 4.507

8.  Efficacy and safety of oral NSAIDs and analgesics in the management of osteoarthritis: Evidence from real-life setting trials and surveys.

Authors:  Jean-Pierre Pelletier; Johanne Martel-Pelletier; François Rannou; Cyrus Cooper
Journal:  Semin Arthritis Rheum       Date:  2015-12-02       Impact factor: 5.532

Review 9.  Nothing Boring About Boron.

Authors:  Lara Pizzorno
Journal:  Integr Med (Encinitas)       Date:  2015-08

10.  Risk factors for osteoporosis and fractures in postmenopausal women between 50 and 65 years of age in a primary care setting in Spain: a questionnaire.

Authors:  Maria Luz Rentero; Cristina Carbonell; Marta Casillas; Milagros González Béjar; Rafael Berenguer
Journal:  Open Rheumatol J       Date:  2008-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.